Nkarta (NKTX) Accumulated Depreciation (2019 - 2026)
Nkarta's (NKTX) quarterly Accumulated Depreciation came in at $31.3 million in Q1 2026, up 35.2% year-on-year from $23.1 million in Q1 2025, and up 8.08% quarter-over-quarter from $29.0 million in Q4 2025.
Nkarta (NKTX) Accumulated Depreciation (2019 - 2026) Analysis & Trends
Nkarta's Accumulated Depreciation history runs 8 years deep, the most recent figure standing at $31.3 million for Q1 2026.
- On a quarterly basis, Accumulated Depreciation rose 35.2% year-over-year to $31.3 million in Q1 2026; TTM through Mar 2026 was $31.3 million, a 35.2% increase from a year earlier, with the FY2025 full-year figure at $29.0 million, up 38.89% from the prior year.
- Accumulated Depreciation grew to $31.3 million in Q1 2026 per NKTX's latest filing, from $29.0 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $31.3 million in Q1 2026 and bottomed at $3.8 million in Q1 2022.
- The 5-year median for Accumulated Depreciation is $13.9 million (2024), against an average of $15.3 million.
- Across the five-year window, Accumulated Depreciation jumped 119.23% in 2022 and surged 35.2% in 2026, its largest moves.
- Year by year, Accumulated Depreciation stood at $5.8 million in 2022, then soared by 100.77% to $11.7 million in 2023, then soared by 78.27% to $20.8 million in 2024, then soared by 38.89% to $29.0 million in 2025, then advanced by 8.08% to $31.3 million in 2026.
- Per Business Quant, the three latest NKTX Accumulated Depreciation figures stand at $31.3 million (Q1 2026), $29.0 million (Q4 2025), and $27.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.29 Mn |
| Dec 31, 2025 | 28.95 Mn |
| Sep 30, 2025 | 27.78 Mn |
| Jun 30, 2025 | 25.48 Mn |
| Mar 31, 2025 | 23.14 Mn |
| Dec 31, 2024 | 20.85 Mn |
| Sep 30, 2024 | 18.56 Mn |
| Jun 30, 2024 | 16.21 Mn |
| Mar 31, 2024 | 13.95 Mn |
| Dec 31, 2023 | 11.69 Mn |
| Sep 30, 2023 | 9.44 Mn |
| Jun 30, 2023 | 7.46 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 5.82 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 3.19 Mn |
| Sep 30, 2021 | 2.63 Mn |
| Jun 30, 2021 | 2.10 Mn |